In the News

Cost Risk Analysis for Chronic Lung Disease in Canada

The three major chronic lung diseases—lung cancer, asthma, and chronic obstructive pulmonary diseaseexact an enormous human and economic toll. With the growth in the number of older Canadians over the next 20 years, it is estimated that the economic burden will exceed $24 billion by 2030. Based on research conducted by the Public Health Agency of Canada, and other sources and advice provided by a number of external experts, The Conference Board of Canada has completed a study that forecasts rates for these respiratory diseases and calculates their associated economic burden over a 20-year period, from 2010–2030. The analysis compares a base-case scenario, in which policymakers take no additional actions to prevent or modify risk factors, with a policy scenario, in which they take a range of actions. The analysis clearly demonstrates the cost savings that can be accrued under a policy scenario versus the base-case scenario.


Study published in the Canadian Respiratory Journal

The Canadian Respiratory Journal recently published the findings of the Canadian population-based study “Awareness of risk factors among persons at risk for lung cancer, chronic obstructive pulmonary disease and sleep apnea” (S. Walker, D.L. Saltman, R. Colucci, L. Martin).
This study received funding under Phase I of the Lung Health Program, and was headed by the Canadian Lung Association. An abstract is available in the November/December 2010 issue of the Canadian Respiratory Journal: volume 17 (6): 287-294.


Government of Canada to help in the effort to control tuberculosis in Nunavut

The Government of Canada announced $800,000 in financial support to Taima TB, a partnership initiative with the Government of Nunavut to help eliminate tuberculosis in Nunavut. 
Key activities of Taima TB — which means STOP TB in Inuktitut — include going door-to-door to diagnose and treat latent TB infections and provide information to individuals on how best to manage their disease. Key partners include Dr. Gonzalo Alvarez, a Consultant Respirologist for Nunavut who is currently affiliated with the Ottawa Hospital Research Institute at the University of Ottawa; Nunavut Tunngavik Inc.; Inuit Tapiriit Kanatami; the National Aboriginal Health Organization; and the New Brunswick Lung Association.
Beginning in 2006, the Public Health Agency of Canada worked with stakeholders to develop the National Lung Health Framework, a strategic action plan to improve the lung health of Canadians. Investment in Taima TB is an important part of this effort.

News Release >>